[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340441-105":59,"doc-detail-340441-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","circulating-cell-free-dna-methylation-based-multi-omics-analysis-allows-early-diagnosis-of-pancreatic-ductal-adenocarcinoma","Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma","","Circulating free DNA methylation profiling combined with genomic multi-omics enables early identification of pancreatic ductal adenocarcinoma (PDAC). The study evaluates a cfDNA-based liquid biopsy assay by running parallel genomic and epigenomic analyses on plasma samples from Chinese PDAC patients and healthy individuals. Cancer-specific methylation alterations distinguish patients from controls, with a six-marker model outperforming a mutation-based model. Integration with CA19-9 further improves diagnostic sensitivity and specificity, supporting non-invasive PDAC detection.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/circulating-cell-free-dna-methylation-based-multi-omics-analysis-allows-early-diagnosis-of-pancreatic-ductal-adenocarcinoma/340441/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/circulating-cell-free-dna-methylation-based-multi-omics-analysis-allows-early-diagnosis-of-pancreatic-ductal-adenocarcinoma/340441.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",18,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of the study?","Question",{"text":113,"@type":114},"To assess the feasibility of a cfDNA-based liquid biopsy assay for diagnosing pancreatic ductal adenocarcinoma using combined genomic and epigenomic signals.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the methylation-based model perform compared with mutation-based approaches?",{"text":118,"@type":114},"The methylation-based diagnostic model using six methylation markers showed higher sensitivity and specificity, outperforming the mutation-based model significantly.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is CA19-9 not sufficient for early-stage PDAC diagnosis?",{"text":122,"@type":114},"CA19-9 has limited sensitivity for early-stage patients and can show false positivity in non-cancerous conditions, restricting its clinical utility.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340441,1790470396,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductaladenocarcinoma  \nGuochao Zhao 1 , Ruijingfang Jiang2, Ying Shi2, Suizhi Gao3, Dansong Wang 1, Zhilong Li2, Yuhong Zhou4, Jianlong Sun2, Wenchuan Wu 1, Jiaxi Peng2, Tiantao Kuang 1, Yefei Rong 1, Jie Yuan5, Shida Zhu6,7, Gang Jin3 , Yuying Wang2  and Wenhui Lou 1   \n1 Department of Pancreatic Surgery, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China  \n2 Envelope Health Biotechnology Co. Ltd. , BGI-Shenzhen, China  \n3 Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital Afﬁliated to Navy Medical University, Shanghai, China  \n4 Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China  \n5 The Fifth Afﬁliated Hospital of Southern Medical University, Guangzhou, China  \n6 BGI Genomics, BGI-Shenzhen, China  \n7 Shenzhen Engineering Laboratory for Innovative Molecular Diagnostics, BGI-Shenzhen, China  \nKeywords  \ncfDNA; liquid biopsy; machine learning; methylation; mutation; pancreatic ductaladenocarcinoma  \nCorrespondence  \nG. Jin, Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital Afﬁliated to Navy Medical University, No.  \n168, Changhai Road, Yangpu District, Shanghai, 200433, China  \nTel: +86 21 31166666  \nE-mail: [jingang@smmu.edu.cn](jingang@smmu.edu.cn)  \nY. Wang, Envelope Health Biotechnology Co. Ltd. , No. 7, BGI-Shenzhen, No. 21, Hong’an 3rd Avenue, Yantian District, Shenzhen, 518083, China  \nTel: +86 755 36307888  \n[E-mail:](E-mail: wangyuying@genomics.cn)[ wangyuying@genomics.cn](E-mail: wangyuying@genomics.cn)[ ](E-mail: wangyuying@genomics.cn)and  \nW. Lou, Department of Pancreatic Surgery, Cancer Center, Zhongshan Hospital, Fudan University, No. 180, Fenlin Road, Xuhui District, Shanghai, 200032, China  \nTel: +86 21 64041990  \nE-mail: [lou.wenhui@zs-hospital.sh.cn](lou.wenhui@zs-hospital.sh.cn)  \nGuochao Zhao and Ruijingfang Jiang contributed equally to this article.  \nPancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with a 5-year survival rate of 7 .2% in China. However, effective approaches for diagnosis of PDAC are limited. Tumor-originating genomic and epigenomic aberration in circulating free DNA (cfDNA) have potential as liquid biopsy biomarkers for cancer diagnosis. Our study aims to assess the feasibility of cfDNA-based liquid biopsy assay for PDAC diagnosis. In this study, we performed parallel genomic and epigenomic proﬁling of plasma cfDNA from Chinese PDAC patients and healthy individuals. Diagnostic models were built to distinguish PDAC patients from healthy individuals. Cancer-speciﬁc changes in cfDNA methylation landscape were identiﬁed, and a diagnostic model based on six methylation markers achieved high sensitivity (88.7% for overall cases and 78.0% for stage I patients) and speciﬁcity (96.8%), outperforming the mutation-based model signiﬁcantly. Moreover, the combination of the methylation-based model with carbohydrate antigen 19-9 (CA19-9) levels further improved the performance (sensitivity: 95.7% for overall cases and 95.5% for stage I patients; speciﬁcity: 93 . 3%) . In conclusion, our ﬁndings suggest that both methylation-based and integrated liquid biopsy assays hold promise as non-invasive tools for detection of PDAC.  \nAbbreviations  \nAF, allele fractions; AUC, area under the curve; CA 19-9, carbohydrate antigen 19-9; cfDNA, circulating cell-free DNA; CGI, CpG islands; CH, clonal hematopoiesis; ctDNA, circulating tumor DNA; CV, cross-validation; DMR, differentially methylated regions; GO, Gene ontology; HMG, high mobility group; iAUC, integrated AUC; MeDEG, methylated-differentially expressed genes; MPS, Methylation-based prognostic scores; NAT, normal tissue adjacent to tumor; NGS, next-generation sequencing; PDAC, pancreatic ductal adenocarcinoma; RFE, recursive feature elimination; ROC, Receiver operation characteristics; RRBS, reduced-representation bisulﬁte sequencing; UMI, ","cbCaivFGeDVlyvnN","https://ap.wps.com/l/cbCaivFGeDVlyvnN","pdf",2330957,13,"English","# Introduction\n## Background of PDAC and diagnostic challenges\n## Limitations of CA19-9\n## Need for improved detection approaches","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To assess the feasibility of a cfDNA-based liquid biopsy assay for diagnosing pancreatic ductal adenocarcinoma using combined genomic and epigenomic signals.\"},{\"question\":\"How did the methylation-based model perform compared with mutation-based approaches?\",\"answer\":\"The methylation-based diagnostic model using six methylation markers showed higher sensitivity and specificity, outperforming the mutation-based model significantly.\"},{\"question\":\"Why is CA19-9 not sufficient for early-stage PDAC diagnosis?\",\"answer\":\"CA19-9 has limited sensitivity for early-stage patients and can show false positivity in non-cancerous conditions, restricting its clinical utility.\"}]","Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma | PDF",1790036518,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/495a08a494f012798e5161cdbebf93c2.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85fee6a669f20288b664db5906e35346.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5aee284e452f58faab87e72c8be79d4b.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c77808284ecbb96a539938fb29265ae5.webp",980,1287]